NCT03893591已完成不适用
A Prospective Cohort Study to Examine the Need to Adjust the Dose of Anticoagulant Apixaban When Used in Patients With Atrial Fibrillation and Obesity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 82
- 试验地点
- 1
- 主要终点
- Anti Xa level of patients with atrial fibrillation and obesity while treatment of Apixaban.
研究概览
简要总结
A prospective cohort study to determine whether a high body weight (BMI equal to or greater than 35 kg / m 2) has an effect on anticoagulant Apixaban level in the blood of patients with atrial fibrillation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hospitalized Patients on Steady State level of Apixaban, based on the data given in the hospital ward . A level of Steady State is received within two days of treatment.
排除标准
- •acute renal failure
结局指标
主要结局
Anti Xa level of patients with atrial fibrillation and obesity while treatment of Apixaban.
时间窗: 6 month
次要结局
未报告次要终点
研究者
Lee Goldstein
Principal Investigator
HaEmek Medical Center, Israel
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Influence of Body-mass Index on the Outcome of Spinal Anesthesia for Total Knee Replacement ArthroplastySpinal AnesthesiaSuccess or Failure of Spinal AnesthesiaNCT01609517Samsung Medical Center209
已完成
不适用
Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.Type 2 Diabetes MellitusNCT02133118Medical Research Foundation, The Netherlands16,293
已完成
不适用
Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic StudiesSleep ApneaAdverse EventNCT03436381The Cleveland Clinic350
已完成
不适用
A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular DiseaseOverweightObesityNCT05873660Novo Nordisk A/S5,360
已完成
不适用
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19COVID-19 PandemicObesityNCT05771857Mohammed VI University Hospital415